Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Friday, September 4, 2026John SterlingView original

Medicines Discovery Catapult provided its investment and expert support to help two biotech companies accelerate the development of new treatments for a range of autoimmune, inflammatory, and age-related diseases.

The post Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases appeared first on GEN - Genetic Engineering and Biotechnology News.